Related Experiment Videos
Genetic heterogeneity of familial hypertrophic cardiomyopathy
1INSERM U127, Hôpital Lariboisière, Paris, France.
Insights
Genetic analysis identified novel mutations in the beta-myosin heavy chain gene causing familial hypertrophic cardiomyopathy (FHC). A new FHC locus was also discovered on chromosome 11, highlighting genetic heterogeneity.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Familial hypertrophic cardiomyopathy (FHC) is an inherited cardiac condition.
- It is characterized by autosomal dominant transmission, left ventricular hypertrophy, and myocardial disorganization.
- Genetic heterogeneity for FHC has been previously suggested.
Purpose of the Study:
- To identify the genetic basis of FHC in French families.
- To investigate the beta-myosin heavy chain (beta-MHC) gene and search for novel FHC loci.
Main Methods:
- Linkage and haplotype analysis were performed on 17 French families using microsatellite markers.
- Genetic screening was conducted to identify mutations in affected individuals.
- Genome-wide screening was employed in families excluded for the known beta-MHC locus.
Main Results:
- Two novel missense mutations in exon 13 of the beta-MHC gene were identified.
- These mutations led to arginine replacement by leucine or tryptophan at position 403.
- A new FHC locus was discovered on chromosome 11 in one family.
Conclusions:
- The beta-myosin heavy chain gene is implicated in FHC through specific mutations.
- Genetic heterogeneity exists in FHC, with novel loci contributing to the disease.
- Further research into these genetic factors is crucial for understanding and diagnosing FHC.
Abstract:
Familial hypertrophic cardiomyopathy (FHC) is characterized by an autosomal dominant transmission, a left ventricular hypertrophy and a myocardial disorganization. A first morbid gene coding for the beta-myosin heavy chain (beta-MHC) located on chromosome 14q11-q12 has been identified and genetic heterogeneity has been demonstrated. We performed linkage and haplotype analysis of 17 French families with microsatellite markers located to the beta-MHC locus and we searched for a new locus in a family for which the beta-MHC locus was excluded. Two novel missense mutations were identified in exon 13 of the beta-MHC resulting in the replacement of 403 arginine by a leucine or a tryptophan in two different families. In one other family, systematic screening of the genome with highly informative markers allowed us to find a new locus for FHC on chromosome 11.